Brookfield Corp’s Frontline FRO Stock Holding History

Brookfield Corp’s Portfolio FRO Stock Details FRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-42,497	Closed	-$704K	–	650
2023 Q1	$704K	Buy	+42,497	New	+$669K	﹤0.01%	548

Other funds holding FRO

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Brookfield Corp's FRO Position: Q2 2023 in Review

Brookfield Corp sold out of Frontline (FRO) in Q2 2023, closing a stake of 42,497 shares — an estimated $704K sold.

Brookfield Corp first reported a position in FRO in Q1 2023 and held it in 1 quarter. The position peaked at $704K in Q1 2023. 163 funds tracked by Wall St. Rank hold FRO as of Q2 2023.

Brookfield Corp reported no remaining Frontline position as of Q2 2023 after selling out during the quarter.
Brookfield Corp sold 42,497 Frontline shares in Q2 2023, an estimated $704K.
Brookfield Corp first reported a position in Frontline in Q1 2023 and held it in 1 quarter.
Brookfield Corp's Frontline position peaked at $704K in Q1 2023.
163 funds tracked by Wall St. Rank held Frontline as of Q2 2023.

Based on Brookfield Corp's 13F filing for Q2 2023, filed 14 Aug 2023.